A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model

2K views

DOI:

10.3791/63839

November 11th, 2022

In This Article

Summary

This protocol provides a step-by-step procedure for executing multiple intravenous bolus dose administration and invasive hemodynamic monitoring in mice. Investigators can use this protocol for future therapeutic compound screening for pulmonary artery hypertension.

Abstract

Pulmonary arterial hypertension (PAH) is a progressive life-threatening disease, primarily affecting small pulmonary arterioles of the lung. Currently, there is no cure for PAH. It is important to discover new compounds that can be used to treat PAH. The mouse hypoxia-induced PAH model is a widely used model for PAH research. This model recapitulates human clinical manifestations of PAH Group 3 disease and is an important research tool to evaluate the effectiveness of new experimental therapies for PAH. Research using this model often requires the administration of compounds in mice. For a compound that needs to be given directly into the bloodstream, optimizing intravenous (IV) administration is a key part of the experimental procedures. Ideally, the IV injection system should permit multiple injections over a set time course. Although the mouse hypoxia-induced PAH model is very popular in many laboratories, it is technically challenging to perform multiple IV bolus dosing and invasive hemodynamic assessment in this model. In this protocol, we present step-by-step instructions on how to carry out multiple IV bolus dosing via mouse jugular vein and perform arterial and right ventricle catheterization for hemodynamic assessment in mouse hypoxia-induced PAH model.

Introduction

Pulmonary artery hypertension (PAH) is defined by a mean pulmonary artery systolic pressure greater than 20 mmHg at rest1,2. It is a progressive and fatal disease characterized by a sustained elevation in pulmonary arterial pressure, leading to right ventricle overload and ultimately death due to right ventricular failure1. Currently, there is no cure for PAH.

The use of animal models of pulmonary hypertension is important for testing the effectiveness of experimental PAH therapies. Among those models, the mouse hypoxia-induced PAH model has provided key insi....

Access restricted. Please log in or start a trial to view this content.

Protocol

All animal procedures were performed under protocols approved by Yale University Institutional Animal Care and Use Committees.

1. Preparation of animals, tools, blood pressure measuring equipment, and hypoxia chamber

  1. Animal acclimation.
    NOTE: Experimental animals used for this study were male, 8-week-old C57BL/6 mice weighing 25-27 g. Several factors should be considered when estimating the number of animals required for the experiment, including surgery-associated mortality, unexpected surgical complications, and sudden unexpected death. Use at least 10 mice per group to reach statistical power and avoid....

Access restricted. Please log in or start a trial to view this content.

Results

Anesthesia often reduces blood pressure. Therefore, a minimum dose of anesthesia was used to abolish the movements in response to a noxious stimulus. Successful right ventricular chamber access can be visualized as the hemodynamic waveform changes in different regions of venous systems (Figure 8).

In this study, mice were randomly assigned to the normoxic (21% O2) group (n = 10), hypoxia (10% O2) group (n = 10), or hypoxia + 7C1/let-7 treatme.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Several pulmonary hypertension animal models have been established to mimic the elevated pulmonary vascular resistance events in human subjects. Among them, the mouse hypoxia-induced PAH model has been widely used for evaluating the effectiveness of new experimental therapies for PAH. Research using this model often requires the administration of compounds to the mice. In comparison with other published intravenous (IV) injection and invasive hemodynamic assessment protocols, this method provides both visual illustration.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

K Zsebo, M Simons, and P-Y Chen are scientific founders and shareholders of VasoRx, Inc. M Simons is a member of the Scientific Advisory Board of VasoRx, Inc. HJ Duckers is an employee and shareholder of VasoRx. The other authors declare no competing interests.

Acknowledgements

This work was supported, in part, by a Joint Biology Consortium Microgrant provided under NIH grant P30AR070253 (PYC), Cardiovascular Medical Research Education Fund (PYC), VasoRx, Inc. Fund (MS) and NIH grants HL135582 (MS), HL152197 (MS).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
5-0 prolene suture packEthicon8698Gfor incision closure
8-0 nylon suture packAROSurgical InstrumentsT06A08N14-13for ligation
Anesthesia induction chamberVETEQUIP#941444Holds the animal during anesthesia exposure
Catheter Interface Cable PEC-4DMillarfor connecting Millar Mikro-Tip catheter to PCU-2000
Charcoal canister filtersVETEQUIP#931401 to help remove waste anesthetic gases
Cotton swabsMcKesson24-106for applying pressure to the injection site to prevent bleeding
Fine scissorsFine Science Tools14059-11Surgical tools
Insulin syringe 28 GEXEL26027for jugular vein IV injection
IsofluraneCOVETRUS#029405for mouse anesthesia
LabChart 8 SoftwareADInstrumentsfor data analysis
Mikro-Tip Pressure Catheter SPR-1000 (1.0 F)Millarfor invasive blood pressure measurement
Needle-25 GBD305124for making a samll hole in a vessel
Oxygen controller ProOx Oxygen SensorBioSpherixE702for oxygen concentration monitoring
PCU-2000 Pressure Control UnitMillarfor connecting Millar Mikro-Tip catheter to PowerLab 4/35
PowerLab 4/35ADInstrumentsfor Data Acquisition.
Investigator needs to connect the PowerLab 4/35 to a personal laptop containing LabChart 8 software for operation.
Prism 8GraphPadfor statistics and scientific graphing
Semisealable hypoxia chamberBioSpherixan artificial environment that simulates high-altitude conditions for animals
Spring ScissorsFine Science Tools15021-15Surgical tools
Tweezer Style 4Electron Microscopy Sciences0302-4-POSurgical tools
VasoRx compound 7C1/let-7 miRNAVasoRx, Inc.Lot# B2-L-16AprIV injection compound
VIP 3000 Veterinary VaporizerCOLONIAL MEDICAL SUPPLY CO., INC.for accurate anesthesia delivery

References

  1. McLaughlin, V. V., McGoon, M. D. Pulmonary arterial hypertension. Circulation. 114 (1), 1417-1431 (2006).
  2. Hoeper, M. M., Humbert, M. The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally. European Respiratory Journal. 53....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Pulmonary Arterial HypertensionHypoxia Mouse ModelJugular Vein InjectionRight Ventricle CatheterizationArterial CatheterizationBlood Pressure MeasurementDrug Development ScreeningCatheter Insertion